Oderda, M., Orlando, G., Calleris, G., Capella, G., Delsedime, L., Duregon, E., . . . Gontero, P. (2025). Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance. Wiley. https://doi.org/10.1002/pros.24921
Style de citation Chicago (17e éd.)Oderda, Marco, et al. Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance. Wiley, 2025. https://doi.org/10.1002/pros.24921.
Style de citation MLA (9e éd.)Oderda, Marco, et al. Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance. Wiley, 2025. https://doi.org/10.1002/pros.24921.